Dark
Light
System
Security
Crispr Therapeutics
Crispr Therapeutics. Institutional holdings reported to the SEC.

Institutional Holders (2016Q4)
Portfolio Summary: 26 Institutional holders with a total value of $197,779,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 NEA Management Company, LLC 3,220,728 65,252,000 32.99%
2 Abingworth LLP 2,601,814 52,036,000 26.31%
3 CLOUGH CAPITAL PARTNERS L P 838,791 16,676,000 8.43%
4 WELLINGTON MANAGEMENT GROUP LLP 744,380 15,007,000 7.59%
5 FRANKLIN RESOURCES INC 729,333 14,389,000 7.28%
6 New Leaf Venture Partners, L.L.C. 586,475 11,882,000 6.01%
7 ORBIMED ADVISORS LLC 372,191 7,541,000 3.81%
8 Novo Holdings A/S 223,317 4,524,000 2.29%
9 LORD, ABBETT & CO. LLC 211,700 4,289,000 2.17%
10 VIVO CAPITAL, LLC 148,878 3,016,000 1.52%
11 JHL Capital Group LLC 60,000 1,216,000 0.61%
12 Laurion Capital Management LP 26,000 527,000 0.27%
13 BANK OF AMERICA CORP /DE/ 21,500 436,000 0.22%
14 GEODE CAPITAL MANAGEMENT, LLC 18,350 371,000 0.19%
15 MILLENNIUM MANAGEMENT LLC 11,913 241,000 0.12%
16 MONASHEE INVESTMENT MANAGEMENT LLC 7,186 146,000 0.07%
17 UBS Group AG 4,042 82,000 0.04%
18 MORGAN STANLEY 3,816 77,000 0.04%
19 WELLS FARGO & COMPANY/MN 980 20,000 0.01%
20 SALEM INVESTMENT COUNSELORS INC 650 13,000 0.01%
21 LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 600 12,000 0.01%
22 Tower Research Capital LLC (TRC) 479 10,000 0.01%
23 INTELLECTUS PARTNERS, LLC 325 7,000 0.00%
24 ELGETHUN CAPITAL MANAGEMENT 300 6,000 0.00%
25 CRIBSTONE CAPITAL MANAGEMENT, LLC 90 2,000 0.00%
26 TAYLOR WEALTH MANAGEMENT PARTNERS 50 1,000 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.